Order results by:
| Issue | Title | |
| Vol 13, No 5 (2017) | RIVAROXABAN OF THE BAYER COMPANY SIGNIFICANTLY (BY 24%) REDUCES THE RISK OF STROKE, CARDIOVASCULAR DEATH AND MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE OR PERIPHERAL ARTERIAL DISEASE | Abstract similar documents |
| статья Редакционная | ||
| "... Press release of JSC "BAYER" ..." | ||
| Vol 14, No 5 (2018) | Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA | Abstract similar documents |
| Bayer Company Press Release | ||
| Vol 13, No 1 (2017) | DATA OF THE RECENTLY PUBLISHED SWISS STUDY SWIVTER (THE SWISS VENOUS THROMBOEMBOLISM REGISTRY) DEMONSTRATE THE REPRODUCIBILITY OF THE RESULTS OF RANDOMIZED TRIALS IN REAL CLINICAL PRACTICE | Abstract similar documents |
| статья Редкционная | ||
| "... Press Release of the Bayer Company ..." | ||
| Vol 13, No 2 (2017) | RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY | Abstract similar documents |
| . Editorial | ||
| "... Press Release of Bayer AG ..." | ||
| Vol 12, No 6 (2016) | NEW DATA OF EXTENSIVE RESEARCH PROGRAM AND THE RESULTS OF STUDIES IN REAL CLINICAL PRACTICE FROM DIFFERENT COUNTRIES REAFFIRMED THE HIGH EFFICACY AND A FAVORABLE SAFETY PROFILE OF RIVAROXABAN (XARELTO®) FROM THE BAYER COMPANY PRESS RELEASE OF THE BAYER COMPANY | Abstract similar documents |
| article editorial | ||
| Vol 16, No 3 (2020) | A Case of Whipple's Disease Related Infectious Endocarditis | Abstract similar documents |
| N. V. Ivanova, V. Y. Zimina, F. I. Bitakova, Yu. N. Grishkin, S. A. Saiganov | ||
| "... Whipple's disease is caused by Tropheryma whipplei and is known to have protean clinical ..." | ||
| Vol 14, No 6 (2018) | The Results of Rivaroxaban Studies COMMANDER HF and MARINER Were Published. Bayer Company Press Release . | Abstract PDF (Eng) similar documents |
| artilce Editorial | ||
| Vol 15, No 3 (2019) | Treatment of Patients with Stable Manifestations of Atherosclerosis: New Opportunities | Abstract similar documents |
| article Editorial | ||
| "... BAYER Elovoy-Vronskiy A.A.. The resolution discusses the issues of diagnosis and management ..." | ||
| Vol 12, No 4 (2016) | New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) | Abstract similar documents |
| Article Editorial | ||
| "... Компания Bayer AG и ее партнер Janssen Pharmaceuticals, Inc. объявили о результатах нового ..." | ||
| Vol 21, No 2 (2025) | Diagnostic performance of the 2019 ESC pre-test probability and Coronary Artery Disease consortium models in estimating obstructive coronary artery disease | Abstract PDF (Eng) similar documents |
| Huy Truong Hoang, Dan Van Buu Do, Thao Le Phuong Nguyen, V. V. Maiskov, Z. D. Kobalava | ||
| "... pre-test probability (PTP) model and the coronary artery disease (CAD) consortium basic and clinical ..." | ||
| Vol 9, No 3 (2013) | STATINS AND RISK OF INFECTIOUS DISEASES | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... , and pneumonia particularly. Results of the large studies on statin influence on infectious disease are presented. ..." | ||
| Vol 10, No 1 (2014) | MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) | Abstract PDF (Eng) similar documents |
| A. M. Kalinina | ||
| "... of subjects who have died of ischemic heart disease (IHD) undiagnosed during life-time. To estimate ..." | ||
| Vol 10, No 6 (2014) | VALIDATION OF THE MACNEW QUESTIONNAIRE FOR THE ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ISHEMIC HEART DISEASE | Abstract PDF (Eng) similar documents |
| N. V. Pogosova, A. A. Kursakov, I. H. Boycharov, S. Höfer, N. Oldridge | ||
| "... ) in both global and Russian practice. In many countries HRQL in patients with ischemic heart disease (IHD ..." | ||
| Vol 7, No 3 (2011) | REDUCTION DEGREE OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL LEVELS ACCORDING TO DIFFERENT DOSES OF STATINS; ITS EFFECT ON THE RISK OF ISCHEMIC HEART DISEASE ACUTE EPISODES DEPENDING ON TREATMENT DURATION; AND RISK OF ISCHEMIC AND THROMBOEMBOLIC STROKE. COMMENT ON THE PAPER OF LAW M.R., WALD N.J., RUDNICKA A.R. QUANTIFYING EFFECT OF STATINS ON LOW DENSITY LIPOPROTEIN CHOLESTEROL, ISCHAEMIC HEART DISEASE, AND STROKE: SYSTEMATIC REVIEW AND META-ANALYSIS. BMJ 2003; 326:1423-1427 | Abstract similar documents |
| N. V. Perova | ||
| "... decrease in LDL cholesterol levels on 1.0 or 1.8 mmol/l leads to rate reduction in ischemic heart disease ..." | ||
| Vol 4, No 1 (2008) | COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE | Abstract similar documents |
| N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich | ||
| "... Co. Ltd", Russia) and Aspirin cardio («Bayer AG», Germany), in patients with arterial hypertension ..." | ||
| Vol 5, No 4 (2009) | COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS | Abstract PDF (Eng) similar documents |
| N. A. Karoli, A. P. Rebrov | ||
| "... Aim. To study prevalence and features of cardiovascular diseases (arterial hypertension, ischemic ..." | ||
| Vol 10, No 1 (2014) | ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES | Abstract similar documents |
| J. D. Kobalava, Yu. V. Kotovskaya, S. V. Villevalde, A. E. Soloveva, I. M. Amirbegishvili | ||
| "... Chronic kidney disease (CKD) is associated with increased cardiovascular risk. CKD ..." | ||
| Vol 8, No 1 (2012) | RANOLAZINE IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| V. P. Lupanov | ||
| "... disease are considered. ..." | ||
| Vol 6, No 4 (2010) | HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE | Abstract similar documents |
| G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov | ||
| "... diseases and finally to improve quality of life and life expectancy of these patients. ..." | ||
| Vol 19, No 2 (2023) | Rendu-Osler-Weber Disease with High Pulmonary Hypertension and Interstitial Lung Disease | Abstract similar documents |
| Yu. A. Lutokhina, O. V. Blagova, P. O. Savina, E. V. Zaklyazminskaya | ||
| "... interstitial lung disease. As a result of cardiotropic and diuretic therapy, as well as correction of anemia ..." | ||
| Vol 11, No 2 (2015) | CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION | Abstract similar documents |
| V. N. Shishkova | ||
| "... The question of mutual influence of risk factors for cardiovascular and renal diseases ..." | ||
| Vol 12, No 4 (2016) | Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk | Abstract similar documents |
| O. M. Drapkina, O. N. Korneeva | ||
| "... The problem of non-alcoholic fatty liver disease (NAFLD), which is an independent risk factor ..." | ||
| Vol 13, No 3 (2017) | BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL | Abstract similar documents |
| I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov | ||
| "... dysfunction at the pre-dialysis stage of the disease in order to reduce the risk of progression of chronic ..." | ||
| Vol 11, No 2 (2015) | THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? | Abstract similar documents |
| S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov | ||
| "... with cardiovascular diseases and concomitant chronic liver diseases. Material and methods. Сross-sectional ..." | ||
| Vol 11, No 5 (2015) | Excess winter cardiovascular morbidity in Ivanovo Region in 2009-2013 years | Abstract similar documents |
| A. V. Kontsevaya, J. A. Balanova, M. M. Loukianov, M. B. Khudyakov, O. A. Belova, S. V. Romanchuk | ||
| "... Chronic non-infectious diseases are characterized by irregular morbidity and mortality throughout ..." | ||
| Vol 15, No 2 (2019) | Detectability of Subclinical Hypothyroidism and Thyroid Stimulating Hormone Levels Associated with Cardiovascular Diseases in Patients of North-West Region Hospital | Abstract similar documents |
| A. R. Volkova, O. D. Dygun, O. N. Zhdanova, B. G. Lukichev, L. A. Belyakova, E. M. Sereda | ||
| "... with cardiovascular diseases (CVD) is an important clinical task. Aim. To study the detectability of subclinical ..." | ||
| Vol 15, No 3 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... with the prevalence and mortality from cardiovascular diseases (CVD). The presence of BAC on mammograms is associated ..." | ||
| Vol 13, No 3 (2017) | ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION | Abstract similar documents |
| F. I. Belyalov | ||
| "... The ischemic heart disease (IHD) with comorbid kidney dysfunction has more severe course and worse ..." | ||
| Vol 8, No 3 (2012) | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... in different cardiovascular diseases are obtained. Physiological significance of magnesium is determined by its ..." | ||
| Vol 8, No 4 (2012) | IT IS BETTER TO PREVENT DISEASE THAN TREAT IT | similar documents |
| N. V. Dolgushina | ||
| Vol 5, No 1 (2009) | MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. N. Zakirova, R. G. Oganov, N. E. Zakirova, G. R. Klochkova, F. S. Musina | ||
| "... on disease severity and experienced myocardial infarction (MI). Material and methods. 148 male patients ..." | ||
| Vol 4, No 4 (2008) | ENDOTHELIAL DYSFUNCTION IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. E. Zakirova, R. G. Oganov, A. N. Zakirova, M. P. Plotnikova, G. M. Salakhova | ||
| "... in the development of angina pectoris (AP) in patients with ischemic heart disease (IHD). Material and methods. 83 ..." | ||
| Vol 5, No 3 (2009) | RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov | ||
| "... ) and/or coronary heart disease (CHD) as well as to study risk factors of erectile dysfunction. Material ..." | ||
| Vol 6, No 1 (2010) | THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... diseases (arterial hypertension, ischemic heart disease, chronic heart failure, rhythm disorders ..." | ||
| Vol 6, No 2 (2010) | EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES | Abstract similar documents |
| A. N. Meshkov | ||
| "... of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors ..." | ||
| Vol 7, No 6 (2011) | DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE | Abstract similar documents |
| D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova | ||
| "... hypertension (HT) and chronic ischemic heart disease (CIHD), and to establish their significance and hierarchy ..." | ||
| Vol 11, No 6 (2015) | Alcohol consumption in patients with cardiovascular diseases (results of the survey of cardiac patients in outpatient practice) | Abstract similar documents |
| O. D. Ostroumova, I. E. Nikolaeva, S. Ya. Eregin, I. V. Pokrovskaya, K. A. Ishchenko | ||
| "... diseases and to determine their preferences regarding the help in limiting alcohol consumption. Material ..." | ||
| Vol 8, No 3 (2012) | THE PROBLEM OF THE OPTIMAL PHARMACOTHERAPY CHOICE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE | Abstract similar documents |
| S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina | ||
| "... disease is discussed. Expert’s opinions are presented concerning first-line antiischemic drugs and about ..." | ||
| Vol 4, No 4 (2008) | BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST | Abstract similar documents |
| L. N. Malaj | ||
| "... Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed ..." | ||
| Vol 18, No 1 (2022) | Cardiovascular Effects of Metformin | Abstract similar documents |
| B. T. Kurmanbekova, A. M. Noruizbaeva | ||
| "... , progression and mortality from cardiovascular diseases (CVD). The world communities are faced ..." | ||
| Vol 14, No 2 (2018) | DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT | Abstract similar documents |
| N. В. Perepech, A. V. Tregubov | ||
| "... for primary and secondary prevention of cardiovascular diseases. 276 questionnaires filled out by 185 ..." | ||
| Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
| A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
| "... with atrial fibrillation (AF) and chronic kidney disease (CKD) with modern clinical guidelines. Material ..." | ||
| Vol 17, No 4 (2021) | Novel Biomarkers of Endothelial Dysfunction in Cardiovascular Diseases | Abstract similar documents |
| Z. M. Abdurakhmanov, B. Y. Umarov, M. M. Abdurakhmanov | ||
| "... and progression of cardiovascular diseases, stratification of their risks, since endothelial dysfunction (ED ..." | ||
| Vol 18, No 4 (2022) | Uric Acid as a Risk Factor for Cardiovascular Diseases | Abstract similar documents |
| A. S. Safaryan, A. S. Lishuta, D. V. Nebieridze | ||
| "... Recently, hyperuricemia and its association with cardiovascular disease have been receiving more ..." | ||
| Vol 19, No 1 (2023) | Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities | Abstract similar documents |
| A. V. Gorbenko, Y. P. Skirdenko, K. A. Andreev, M. M. Fedorin, N. A. Nikolaev, M. A. Livzan | ||
| "... types. The link between the gut microbiota and cardiovascular disease (CVD) is being actively ..." | ||
| Vol 17, No 3 (2021) | Prevalence of Musculoskeletal Disorders in Patients with Coronary Artery Disease | Abstract PDF (Eng) similar documents |
| E. D. Bazdyrev, N. A. Terentyeva, K. E. Krivoshapova, V. L. Masenko, E. A. Wegner, А. N. Kokov, S. A. Pomeshkina, O. L. Barbarash | ||
| "... disease (CAD). Material and methods. Patients with stable CAD (n=387) were included in the study ..." | ||
| Vol 13, No 5 (2017) | COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES | Abstract similar documents |
| A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash | ||
| "... Background. The problem of comorbidity in ischemic heart disease (IHD) has always been given ..." | ||
| Vol 7, No 5 (2011) | DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. V. Perova, V. A. Metel'skaya, E. I. Sokolov, G. N. Shchukina, V. M. Fomina | ||
| "... fats on the development of cardiovascular diseases and acute complications due to atherothrombosis ..." | ||
| Vol 9, No 4 (2013) | VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... The problem of varenicline use in patients with cardiovascular diseases is discussed. Results ..." | ||
| Vol 10, No 1 (2014) | MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT | Abstract similar documents |
| E. I. Trisvetova | ||
| "... Progression of cardiovascular disease is often caused by a deficiency of magnesium in the human ..." | ||
| Vol 10, No 4 (2014) | MODERN PRINCIPLES OF QUALITY ASSESSMENT OF CARDIOVASCULAR DISEASES TREATMENT | Abstract similar documents |
| A. Yu. Suvorov, S. Yu. Martsevich | ||
| "... The most common ways of assessment of cardiovascular diseases treatment abroad, approaches ..." | ||
| Vol 15, No 6 (2019) | Coronary Heart Disease in HIV-Infected Patients | Abstract similar documents |
| M. A. Arzhakova, T. A. Shekhovtsova, D. V. Duplyakov | ||
| "... . This led to an increase in their cardiovascular diseases, which occur at an earlier age and are more severe ..." | ||
| Vol 10, No 5 (2014) | CHOICE OF LISINOPRIL FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH CONCOMITANT DISEASES | Abstract similar documents |
| N. A. Dzhaiani | ||
| "... pulmonary disease, elderly patients, and concomitant liver diseases). ..." | ||
| Vol 10, No 3 (2014) | ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
| E. I. Leonova, G. G. Shehan, V. S. Zadionchenko, K. M. Bogatyrova | ||
| "... disease are discussed. The impact of chronic obstructive pulmonary disease treatment on the onset ..." | ||
| Vol 1, No 1 (2005) | NITRATES IN ISCHEMIC HEART DISEASE TREATMENT, YESTERDAY AND TODAY | Abstract similar documents |
| S. N. Tereschenko, N. A. Djaiani, E. V. Iljina | ||
| "... The problem of nitrate formulation choice in treatment of patients with ischemic heart disease ..." | ||
| Vol 1, No 3 (2005) | ASSESSMENT OF CUMULATIVE RISK OF CARDIO-VASCULAR DISEASES | Abstract similar documents |
| S. A. Shalnova, O. V. Vikhireve | ||
| "... Assessment of cumulative risk of cardio-vascular diseases. ..." | ||
| Vol 1, No 3 (2005) | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE | Abstract similar documents |
| G. De Backer, E. Ambrosioni, K. Borch-Johnsen, C. Brotons, R. Cifkova, J. Dallongeville, S. Ebrahim, O. Faergeman, I. Graham, G. Mancia, V. Manger Cats, K. Orth-Gomer, J. Perk, K. Pyorala, J. Rodicio, S. Sans, V. Sansoy, U. Sechtem, S. Silber, T. Thomsen, D. Wood | ||
| "... European guidelines on cardiovascular disease prevention in clinical practice. ..." | ||
| Vol 3, No 2 (2007) | IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. E. Zakirova, N. Kh. Khafizova, I. M. Karamova, A. N. Zakirova, R. G. Oganov | ||
| "... in patients with ischemic heart disease (IHD). Material and methods: The study included 83 patients with IHD ..." | ||
| Vol 3, No 3 (2007) | RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov | ||
| Vol 3, No 4 (2007) | GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES | Abstract similar documents |
| L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, K. Malmberg, S. Priori, J. Ostergren, J. Tuomilehto, I. Thrainsdottir | ||
| "... The Task Force on Diabetes and Cardiovascular diseases of the European Society of Cardiology ..." | ||
| Vol 3, No 4 (2007) | COMMENTS ON GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES | Abstract similar documents |
| An. A. Alexandrov | ||
| "... Comments on Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. ..." | ||
| Vol 3, No 5 (2007) | GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES | Abstract similar documents |
| L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, K. Malmberg, S. Priori, J. Ostergren, J. Tuomilehto, I. Thrainsdottir | ||
| "... The Task Force on Diabetes and Cardiovascular diseases of the European Society of Cardiology ..." | ||
| Vol 14, No 2 (2018) | ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016 | Abstract PDF (Eng) similar documents |
| A. N. Kontsevaya, O. M. Drapkina, Yu. A. Balanova, A. E. Imaeva, E. I. Suvorova, M. B. Khudyakov | ||
| "... Aim. To evaluate the economic burden of cardiovascular diseases (CVD) in the Russian Federation ..." | ||
| Vol 16, No 4 (2020) | Felodipine in Treatment of Arterial Hypertension and Ischemic Heart Disease | Abstract similar documents |
| O. D. Ostroumova, I. A. Alautdinova, A. I. Kochetkov, S. N. Litvinova | ||
| "... Cardiovascular diseases are the leading cause of death both in the world and in the Russian ..." | ||
| Vol 16, No 5 (2020) | Possible Approaches to Primary Prevention of Cardiovascular Diseases | Abstract similar documents |
| V. N. Larina, D. S. Mkrtychev, V. A. Kuznetsova, A. A. Tyazhelnikov | ||
| "... , primary prevention of diseases. However, in most cases, patients seek help from a doctor after ..." | ||
| Vol 16, No 6 (2020) | Chronic Kidney Disease: Current State of the Problem | Abstract similar documents |
| M. M. Batiushin | ||
| "... Chronic kidney disease (CKD) is characterized by increasing prevalence, catalyzing properties ..." | ||
| Vol 17, No 1 (2021) | Cardiomyopathy of Friedreich's Disease. Modern Methods of Diagnostic | Abstract PDF (Eng) similar documents |
| E. I. Fomicheva, R. P. Myasnikov, Y. A. Selivyorstov, S. N. Illarioshkin, E. L. Dadali, O. M. Drapkina | ||
| "... Friedreich's disease is a hereditary neurodegenerative multiple organ disease, primarily affecting ..." | ||
| Vol 17, No 6 (2021) | Heterogeneity of abdominal obesity in patients with cardiovascular diseases | Abstract similar documents |
| S. V. Miklishanskaya, L. V. Solomasova, A. A. Orlovsky, S. N. Nasonova, N. A. Mazur | ||
| Vol 18, No 2 (2022) | Hostility, Anger, Psycho-emotional Factors and Cardiovascular Disease | Abstract similar documents |
| G. F. Andreeva, V. M. Gorbunov | ||
| "... , hostility, anger and cardiovascular diseases. The first chapter describes the main historical stages ..." | ||
| Vol 17, No 5 (2021) | Impact of Gut Microbiota on the Risk of Cardiometabolic Diseases Development | Abstract similar documents |
| L. E. Vasilyeva, O. M. Drapkina | ||
| "... Obesity is a multifactorial disease that leads to excessive adipose tissue accumulation, mainly ..." | ||
| Vol 19, No 3 (2023) | Nutraceutical support in the prevention and treatment of cardiovascular diseases | Abstract similar documents |
| E. V. Gracheva, E. A. Starovoytova, E. S. Kulikov, N. A. Kirillova, S. V. Fedosenko, M. A. Balaganskaya, D. V. Kromka | ||
| "... Cardiovascular disease is the most common cause of death worldwide. In this regard ..." | ||
| Vol 18, No 3 (2022) | Aromatic Amino Acids: Phenylalanine and Tyrosine in Patients with Hypertension and Coronary Artery Disease | Abstract similar documents |
| A. V. Krivova, M. V. Kozhevnikova, E. O. Korobkova, V. Yu. Zektser, E. A. Zheleznykh, А. A. Ageev, N. E. Moskaleva, A. V. Kukharenko, S. A. Appolonova, Yu. N. Belenkov | ||
| "... with cardiovascular diseases (CVD): hypertension and coronary artery disease (CАD) in comparison with healthy study ..." | ||
| Vol 19, No 1 (2023) | Analysis of The Use of PCSK9 Inhibitors in Clinical Practice | Abstract similar documents |
| S. Yu. Volkova, L. A. Boyarskaya, P. Yu. Toropygin, I. A. Morozov, E. A. Boyarskaya | ||
| Vol 12, No 3 (2016) | REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko | ||
| "... of various cardiovascular diseases (CVD) were among participants of the meeting. The importance of modern ..." | ||
| Vol 12, No 5 (2016) | The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies | Abstract similar documents |
| E. K. Butina, E. V. Bochkareva | ||
| "... Measures for the prevention of cardiovascular diseases (CVD) are more effective ..." | ||
| Vol 12, No 6 (2016) | THE PREVALENCE OF ELECTROCARDIOGRAPHIC INDICATORS AMONG MEN AND WOMEN OF OLDER AGES IN THE RUSSIAN FEDERATION | Abstract similar documents |
| G. A. Muromtseva, A. D. Deev, V. V. Konstantinov, A. A. Shalnova, S. A. Boytsov | ||
| Vol 5, No 2 (2009) | DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov | ||
| "... which treat and follow-up patients with cardiovascular diseases (CVD). Material and methods ..." | ||
| Vol 5, No 3 (2009) | ARTERIAL HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| N. M. Nikitina, A. P. Rebrov | ||
| Vol 6, No 1 (2010) | EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS | Abstract PDF (Eng) similar documents |
| D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova | ||
| "... therapy in patients with ischemic heart disease (IHD) after acute coronary events in real practice ..." | ||
| Vol 6, No 1 (2010) | AMLODIPINE IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON ANTIATHEROSCLEROTIC PROPERTIES | Abstract similar documents |
| Yu. M. Lopatin | ||
| "... , amlodipine, in patients with coronary artery disease. Results of randomized clinical trials PREVENT (2000 ..." | ||
| Vol 13, No 1 (2017) | THE LINK BETWEEN VITAMIN В12 DEFICIENCY, RISK OF CARDIOVASCULAR DISEASES AND AGING PROCESS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel | ||
| "... diseases. Usually internists consider that vitamin В12 deficiency is associated with disturbances ..." | ||
| Vol 13, No 1 (2017) | AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. Yu. Shimohina, M. M. Petrova, A. A. Savchenko, M. S. Chernyaeva | ||
| "... of depression in patients with ischemic heart disease (IHD) and to the possibilities of antidepressant therapy ..." | ||
| Vol 13, No 6 (2017) | SMOKING AS A RISK FACTOR OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 1. Smoking Prevalence and Impact on Prognosis | Abstract similar documents |
| O. D. Ostroumova, A. A. Izvekov, N. Yu. Voevodina | ||
| "... heart disease (IHD); cerebral circulation disorders; lower respiratory tract infection; chronic ..." | ||
| Vol 13, No 6 (2017) | FACTORS INFLUENCING ON THE MORTALITY IN PATIENTS WITH OBLITERATING DISEASES OF LOWER LIMB ARTERIES | Abstract similar documents |
| A. N. Sumin, M. A. Kosova, Ju. D. Medvedeva, A. V. Shcheglova, O. I. Rajh, S. A. Makarov, G. V. Artamonova, L. S. Barbarash | ||
| "... diseases of the lower extremities arteries at the stage of outpatient observation. Material and methods ..." | ||
| Vol 14, No 1 (2018) | SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva | ||
| "... quitting smoking the ischemic heart disease (IHD) risk will be 2 folds lower than the risk in smoking ..." | ||
| Vol 6, No 4 (2010) | CORRELATIONS OF LOW MOLECULAR WEIGHT PHENOTYPE OF APOPROTEIN(A) AND SERUM LEVEL OF LIPOPROTEIN(A) WITH MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE | Abstract similar documents |
| O. I. Afanasieva, M. V. Ezhov, M. I. Afanasieva, M. S. Safarova, J. V. Berestetskaya, S. N. Pokrovsky | ||
| "... Background. Atherosclerosis is a systemic disease. That is why the damage is not restricted by one ..." | ||
| Vol 7, No 4 (2011) | METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE | Abstract similar documents |
| M. S. Berezhnova | ||
| "... of cardiovascular disease. There are a lot of approaches to drop smoking including innovative pharmacotherapy ..." | ||
| Vol 6, No 5 (2010) | THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets | ||
| "... electrical cardioversion in patients with ischemic heart disease (IHD) and paroxysmal AF. Material ..." | ||
| Vol 6, No 5 (2010) | PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE | Abstract similar documents |
| M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva | ||
| "... of ED in the majority of men (about 80% of patients) is cardiovascular diseases (atherosclerosis ..." | ||
| Vol 9, No 6 (2013) | DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, A. D. Deev, S. A. Boytsov | ||
| "... At the present time ischemic heart disease (IHD) continues to be the leading cause ..." | ||
| Vol 9, No 1 (2013) | CHARACTERISTICS OF THE TYPES OF LEFT VENTRICULAR REMODELING AMONG WORKING AGE MEN WITH ISCHEMIC HEART DISEASE, LIVING IN ONE OF THE MOUNTAIN REGIONS OF AZERBAIJAN | Abstract similar documents |
| N. R. Ismaylova, F. A. Kuliev, A. F. Zeynalov | ||
| "... types in ischemic heart disease (IHD) among men of working age in one of the mountain regions ..." | ||
| Vol 1, No 1 (2005) | ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES | Abstract similar documents |
| Y. A. Karpov | ||
| "... of the role of ACE inhibitors in treatment of patients with stable form of ischemic heart disease without ..." | ||
| Vol 3, No 1 (2007) | DIZZINESS OF ISCHEMIC GENESIS: DESCRIPTION OF VESTIBULAR DISORDERS AND POSSIBILITY OF THERAPY | Abstract similar documents |
| N. S. Alekseeva | ||
| "... with mild dizziness in initial and reversible cerebrovascular emdiseases/em and estimate the efficacy ..." | ||
| Vol 8, No 3 (2012) | CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| N. P. Lyamina, A. N. Nosenko, I. B. Razborova, O. V. Orlikova, E. V. Kotel'nikova, E. S. Karpova | ||
| "... on diastolic function, depending on the degree of recanalization, in patients with ischemic heart emdisease/em (ICD ..." | ||
| Vol 11, No 6 (2015) | Nephrogenic factors of resistance to antihypertensive treatment in patients with essential hypertension | Abstract similar documents |
| N. V. Teplova, V. A. Lyusov, R. G. Oganov, E. M. Evsikov, R. A. Sharipov, M. H. Zhapoeva, E. G. Kurumlidu | ||
| Vol 3, No 3 (2007) | DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS (PART I) | Abstract similar documents |
| Y. A. Vasyuk, A. V. Lebedev | ||
| "... mechanisms connecting depression and ischemic heart emdisease/em (IHD) are given. Influence of concomitant ..." | ||
| Vol 8, No 4 (2012) | THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| L. E. Chekuldaeva, S. V. Obuhova, A. A. Simakov, L. V. Poljaeva, E. I. Rjazanova | ||
| "... heart emdisease/em (IHD, stable angina; n=55) were included into the study. Patients were randomized ..." | ||
| Vol 8, No 4 (2012) | UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina | ||
| "... cardiovascular emdiseases/em is one of the priorities of modern medicine. This therapy usually consists of several ..." | ||
| Vol 3, No 4 (2007) | DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS. PART II | Abstract similar documents |
| Y. A. Vasyuk, A. V. Lebedev | ||
| "... in myocardial infarction, pathophysiological mechanisms connecting depression and ischemic heart emdisease/em (IHD ..." | ||
| Vol 3, No 4 (2007) | EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
| H. H. Shugushev, M. V. Gurizeva, V. M. Vasilenko | ||
| "... in patients with chronic obstructive pulmonary emdisease/em (COPD). Material and methods. 144 patients with COPD ..." | ||
| 1 - 100 of 946 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
